eberconazole eberconazole eberconazole is an antifungal drug. as a 1% topical cream, it is an effective treatment for dermatophytosis, candidiasis, and pityriasis. eberconazoleclinical datatrade namesebernetlegal statuslegal status us: not fda approved identifiers iupac name 1-(1,3-dichloro-6,11-dihydro-5h-dibenzo annulen-11-yl)imidazole cas number128326-82-9pubchem cid72051chemspider65038uniiv7o1u41c9bcomptox dashboard (epa)dtxsid90926104 chemical and physical dataformulac18h14cl2n2molar mass329.22 g·mol−13d model (jsmol)interactive image smiles c1cc2=cc(=cc(=c2c(c3=cc=cc=c31)n4c=cn=c4)cl)cl inchi inchi=1s/c18h14cl2n2/c19-14-9-13-6-5-12-3-1-2-4-15(12)18(17(13)16(20)10-14)22-8-7-21-11-22/h1-4,7-11,18h,5-6h2key:mptjidogfuqsqh-uhfffaoysa-n it was approved for use in spain in 2015 and is sold under the trade name ebernet. it is also approved for use in panama, guatemala, costa rica, honduras, and the dominican republic.